Search

Your search keyword '"GIANT cell arteritis diagnosis"' showing total 3,691 results

Search Constraints

Start Over You searched for: Descriptor "GIANT cell arteritis diagnosis" Remove constraint Descriptor: "GIANT cell arteritis diagnosis"
3,691 results on '"GIANT cell arteritis diagnosis"'

Search Results

1. MRVAS—introducing a standardized magnetic resonance scoring system for assessing the extent of inflammatory burden in giant cell arteritis.

2. Optic Nerve Sheath Measurement on Ultrasound: A Novel Diagnostic Test for Giant Cell Arteritis.

3. Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association study.

4. Diagnosis of large vessel vasculitis in the community: a specific benefit from a non-specific symptom pathway.

5. Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis.

6. Molecular imaging of large vessel vasculitis.

7. Diffusion-weighted magnetic resonance imaging for the diagnosis of giant cell arteritis: a comparison with T1-weighted black-blood imaging.

8. Determination of the Value of Color Doppler Ultrasound in Patients With a Clinical Suspicion of Giant Cell Arteritis.

9. Step forward towards treat-to-target management of giant cell arteritis: patients stratification aiming to targeted remission – updated guidelines.

10. Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica.

11. Hereditary transthyretin amyloidosis as a mimic of giant cell arteritis: a case report.

12. Clonal haematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls.

13. Giant Cell Arteritis: Focusing on Current Aspects From the Clinic to Diagnosis and Treatment.

14. An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.

15. Giant cell arteritis: Diagnostic difficulties.

16. Reply.

17. Added diagnostic yield of temporal artery magnetic resonance angiography in the evaluation of giant cell arteritis.

18. Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study.

19. Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis.

20. Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis.

21. PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritis.

22. Emergency Medicine Case Study on Giant Cell Arteritis.

23. Intraorbital findings in giant cell arteritis on black blood MRI.

25. A case of polymyalgia rheumatica complicated with giant thoracic aortic aneurysm with massive intraluminal thrombosis.

26. Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis.

27. Optimizing the use of temporal artery biopsy: a retrospective study.

28. Neuro-ophthalmology malpractice: A review of the Westlaw Database.

29. [Variable presentation of giant cell arteritis].

30. Diagnostic performance of a newly launched Canadian fast-track ultrasound clinic by rheumatologists for the diagnosis of giant cell arteritis.

31. Current and Emerging Approaches to Imaging Large Vessel Vasculitis.

32. Imaging Challenges and Developments in Large-vessel Vasculitis.

33. Deep Learning to Discriminate Arteritic From Nonarteritic Ischemic Optic Neuropathy on Color Images.

34. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies.

35. Optical frequency domain imaging (OFDI) represents a novel technique for the diagnosis of giant cell arteritis.

36. [Recommendations for defining giant cell arteritis fast-track clinics].

37. Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group.

38. Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey.

39. Epidemiology of large vasculitis in Shanghai, China: A 10-year multicenter hospital-based study and systematic review.

40. Temporal arteritis presenting as third nerve palsy - a case report and review of literature.

41. Bilateral juvenile temporal arteritis: a case-based review.

43. Uveitis in Giant Cell Arteritis: A Retrospective Study of Seven Observational Cases and Literature Review.

44. Utility of online GCA risk models in predicting the result of temporal artery biopsy within a clinical setting: study of diagnostic and screening tests.

45. A low Southend Giant Cell Arteritis Probability Score negates the need for a temporal artery biopsy in general and eye hospital cohorts.

46. Time to flare in giant cell arteritis and polymyalgia rheumatica: analysis from a single‐centre Australian practice.

47. Clinical Images: Crowned dens syndrome detected on 18F‐fludeoxyglucose–positron emission tomography/computed tomography during investigation for giant cell arteritis.

48. Rho Kinase Expression in Giant Cell Arteritis: Validating Phosphorylated Ezrin/Radixin/Moesin Intensity Score to Increase Sensitivity of Temporal Artery Biopsy.

49. Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.

50. A diagnostic performance study of the 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis in a cohort of patients presenting with suspected giant cell arteritis.

Catalog

Books, media, physical & digital resources